Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma.
George M RamzyMaxim NorkinThibaud KoesslerLionel VoirolMathieu TihyDina HanyThomas McKeeFrédéric RisNicolas BuchsMylène DocquierChristian TosoLaura Rubbia-BrandtGaetan BakalliStéphane GuerrierJoerg HuelskenPatrycja Nowak-SliwinskaPublished in: Journal of experimental & clinical cancer research : CR (2023)
Our approach allows the optimization of patient-tailored synergistic multi-drug combinations within a clinically relevant timeframe.